Can I read Deep sclerectomy and trabeculectomy augmented with Mitomycin C: 2-year post-operative outcomes on EtoBox?

Deep sclerectomy and trabeculectomy augmented with Mitomycin C: 2-year post-operative outcomes by Rahul Dwivedi; Tobi Somerville; Robert Cheeseman; Clare Rogers; Mark Batterbury; Anshoo Choudhary is a Medicine article available to read on EtoBox.

What is Deep sclerectomy and trabeculectomy augmented with Mitomycin C: 2-year post-operative outcomes about?

Purpose Two-year post-operative outcomes of both deep sclerectomy (DS) and trabeculectomy surgery (Trab) augmented with Mitomycin C (MMC) at a single tertiary eye centre. Methods Retrospective review of DS + MMC and trabeculectomy + MMC at a single centre between February 2015 and March 2018. Patients with a minimum of 12-month follow-up were included. Post-operative follow-up: day 1, week 1, months 1/3/ 6/12/18/24. Primary outcomes: changes in intraocular pressure (IOP) and changes in LogMAR visual acuity (BCVA) pre-and postprocedure. Secondary outcomes: changes in number of eye drops, number of follow-up clinic visits, post-operative complications and further surgical interventions. Complete success: IOP ≤ 21 mmHg off all IOP-lowering medications. Qualified success: IOP ≤ 21 mmHg on medication. Failure: IOP > 21 mmHg at 24 months or ≤ 5 mmHg on 2 consecutive follow-up visits after 3 months +/-additional incisional glaucoma surgery +/-loss of light perception. Statistical analysis performed using Microsoft Excel + SPSS. Results 90 eyes: DS + MMC = 46 eyes, Trab + MMC = 44 eyes. DS + MMC v Trab + MMC: mean pre-op IOP = 19.57 mmHg v 18.89 mmHg, significantly reduced at all post-oper

Who reads Deep sclerectomy and trabeculectomy augmented with Mitomycin C: 2-year post-operative outcomes?

Author

Rahul Dwivedi; Tobi Somerville; Robert Cheeseman; Clare Rogers; Mark Batterbury; Anshoo Choudhary

Publisher

Springer Science and Business Media LLC

Published

2021

Language

EN

Field

Medicine (Health Sciences)